Similar articles

• Active specific immunotherapy for acute myelogenous leukaemia.

  Powles R. Powles R. Johns Hopkins Med J Suppl. 1974;3:333-40. Johns Hopkins Med J Suppl. 1974. PMID: 4609353 No abstract available.
• Immunotherapy for acute myelogenous leukemia using irradiated and unirradiated leukemia cells.

  Powles R. Powles R. Cancer. 1974 Oct;34(4 Suppl):suppl:1558-62. doi: 10.1002/1097-0142(197410)34:8+<1558::aid-cncr2820340830>3.0.co;2-h. Cancer. 1974. PMID: 4608692 No abstract available.
• Perspectives and prospectives in the management of acute leukemia.

  Henderson ES. Henderson ES. Hamatol Bluttransfus. 1976;19:305-10. doi: 10.1007/978-3-642-87524-3_32. Hamatol Bluttransfus. 1976. PMID: 795745 No abstract available.
• Immunotherapy of human leukemia.

  Baker MA, Taub RN. Baker MA, et al. Mt Sinai J Med. 1972 Nov-Dec;39(6):548-65. Mt Sinai J Med. 1972. PMID: 4565179 Review. No abstract available.
• BCG and cancer.

  Bast RC Jr, Zbar B, Borsos T, Rapp HJ. Bast RC Jr, et al. N Engl J Med. 1974 Jun 27;290(26):1458-69. doi: 10.1056/NEJM197406272902605. N Engl J Med. 1974. PMID: 4598691 Review. No abstract available.